Tell me where Claude and I got this wrong
The U.S. doesn't have a drug problem—it has a $360B+ middleman rebate problem.
List prices are inflated just to fund PBM spreads, fees, and retrospective rebates.
A blueprint to fix it: An Open Federal Formulary + Transparent Cost-Plus
Pricing 🧵👇